Skin Condition Clinical Trials

Two women talking about clinical careOHSU Department of Dermatology's Clinical Research Team provides expertise in clinical research. We offer many different clinical  trials throughout the year throughout various skin conditions. Most trials have a limited number of spots or time allowed to enroll patients.


Currently Enrolling Trials

Atopic Dermatitis (Eczema)


Effects of Calcipotriene Foam, 0.005%, in Pediatric Subjects (Ages 2 to 11
Years) with Plaque Psoriasis

The purpose of this study is to learn more about psoriasis in children and how a foam treatment acts on the body and scalp.

Ixekizumab in Patient from 6 to Less than 18 Years of Age with
Moderate-to-Severe Plaque Psoriasis

This study is being done to see how safe an investigational drug called ixekizumab is and how well it will work to help people with plaque psoriasis


War on Melanoma: Enlisting a cohort of melanoma survivors and their families
The purpose of this data repository, called the Melanoma Community Registry, is to develop a prospective cohort of melanoma patients, family members and friends (controls). This registry will serve as a data repository for future IRB-approved research and thus will collect, store and share data with melanoma researchers for an indeterminate period of time. In addition, our repository will contain identifying codes/numbers that are links to data/samples in other relevant databases. Additionally, it is intended to deliver a ready-to-act group of volunteers to participate in the War on Melanoma campaign to include such things as attending educational symposiums and using their networks to increase awareness of the issue. There is no existing nationwide registry for melanoma research. As patient-centered research advances, a resource like this is needed and can serve as a model.


Contact Us

To learn more about trials that you may qualify for, as well as for our complete list of active trials, contact us today!

Contact us form

Clinical Trials Coordinator

Our clinical trials in the press

Targeted drug tames atopic eczema in Phase III trials
Eczema - Dupilumab - Dr. Eric Simpson

New Drug for Severe Eczema Is Successful in 2 New Trials
Eczema - Dupilumab - Dr. Jon Hanifin

Are You Bathing Your Baby Too Much?
Pediatric Eczema - Dr. Eric Simpson